Single agent therapy for infections in cancer patients: A prospective randomized trial comparing three extended-spectrum cephalosporins K. V. I. RolstonP. G. JonesG. P. Bodey Article Pages: 139 - 145
Repeated polymerase chain reaction complementary to other conventional methods for early detection of HIV infection in infants born to HIV-infected mothers C. RudinH. P. SennP. Erb Article Pages: 146 - 156
Activity of antiseptics against biofilms of mixed bacterial species growing on silicone surfaces D. SticklerP. Hewett Article Pages: 157 - 162
Interpretive criteria for disk diffusion susceptibility testing of sparfloxacin F. H. KayserJ. Wüst Notes Pages: 163 - 166
Transport conditions and number of biopsies necessary for culture ofHelicobacter pylori M. KjøllerA. FischerT. Justesen Notes Pages: 166 - 167
Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin A. L. BarryP. C. Fuchs New Antimicrobial Agents Pages: 168 - 171
Peritonitis due toMycoplasma hominis andUreaplasma urealyticum in a liver transplant recipient M. HallerH. ForstK. Peter Letters Pages: 172 - 172
Failure of fluconazole therapy inCandida krusei fungemia B. L. RøderC. SonnenscheinS. H. Hartzen Letters Pages: 173 - 173
Some aspects of the epidemiology of toxoplasmosis and pneumocystosis in AIDS in Europe N. Clumeck Current Topic: Notes Pages: 177 - 178
An overview of the problem of toxoplasmosis and pneumocystosis in AIDS in the USA: Implication for future therapeutic trials B. J. LuftK. G. Castro Current Topic: Notes Pages: 178 - 181
Treatment of acute toxoplasmosis with oral clindamycin K. V. I. Rolston Current Topic: Notes Pages: 181 - 183
Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system B. RufH. D. Pohle Current Topic: Notes Pages: 183 - 186
A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine C. Uberti FoppaT. BiniM. Moroni Current Topic: Notes Pages: 187 - 189
Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS C. Katlama Current Topic: Notes Pages: 189 - 191
Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis C. LeportC. TournerieJ. L. Vildé Current Topic: Notes Pages: 191 - 193
Treatment of acute toxoplasmosis with intravenous clindamycin B. R. DannemannJ. A. McCutchanthe California Collaborative Treatment Group Current Topic: Notes Pages: 193 - 195
Clinical programs for clinical research on AIDS: Description of a randomized prospective study of clindamycin versus pyrimethamine for prevention ofToxoplasma gondii infection M. A. JacobsonC. L. BeschL. Deyton Current Topic: Notes Pages: 195 - 198
Models for evaluating compounds for activity againstPneumocystis carinii M. S. Bartlett Current Topic: Notes Pages: 199 - 201
Studies of the susceptibility ofPneumocystis carinii to clindamycin/primaquine in rats J. W. Smith Current Topic: Notes Pages: 201 - 203
Clindamycin and primaquine as primary treatment for mild and moderately severePneumocystis carinii pneumonia in patients with AIDS J. R. BlackJ. FeinbergF. R. Sattler Current Topic: Notes Pages: 204 - 207
Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment ofPneumocystis carinii pneumonia B. RufI. RohdeH. D. Pohle Current Topic: Notes Pages: 207 - 210
Clindamycin/primaquine for treatment ofPneumocystis carinii pneumonia in AIDS E. Toma Current Topic: Notes Pages: 210 - 213
ISSSI-7 VIIth international symposium on staphylococci and staphylococcal infections June 29 – July 3, 1992, Stockholm, Sweden Legacy Pages: 214 - 214
